Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]
-Aishila Kar, Amity University Kolkata The Indian Council of Medical Research (ICMR) in partnership with Hyderabad-based vaccine maker Biological E, has developed a “highly purified antisera” which will be utilized in the prevention and treatment of Covid-19. Antisera are blood sera that carry antibodies against a selected viral toxin or antigen and are introduced to […]
-Shristi Sharma, Team bioXone Researchers from Duke University have found a drug against enterovirus 71, a virus that causes hand, foot, and mouth disease in infants and young children. While many patients recover in a week after sustaining fever and rashes, some even face paralysis and brain edema in severe cases. The drug compound in […]
– Sagnik Nag, Amity University Kolkata Cerebrospinal fluid (CSF) protects the CNS from physical injuries as well as portrays immuno-surveillance over a pathogenic attack. In recent scientific research conducted by Pappalardo et al. profiled the T-cells present in the cerebrospinal fluid (CSF) of a healthy individual. It is known that T-cells ( be it CD4+ or […]
